Home / BusinessBusinessBloombergBusinessBloomberg·Aug 24, 2026·1 min readQiagen Names Jonathan Pratt as CEO as Sale Talks ProgressQiagen NV has appointed Jonathan Pratt as its new chief executive officer, as talks with private equity firms about a possible sale of the European molecular testing company progress.View original source — Bloomberg ↗ShareCopy linkShare on XShare on FacebookRelated storiesBusinessRio TimesBusinessAug 24, 2026 · 1 minLatin America’s Oil Money and the US Squeeze on IranRio TimesBusinessRio TimesBusinessAug 24, 2026 · 1 minChile’s Long-Term Borrowing Costs Hit an 18-Month High as Growth StallsRio TimesBusinessRio TimesBusinessAug 24, 2026 · 1 minArgentina’s Central Bank Reserves Reach a Record US$50.655 BillionRio TimesBusinessRio TimesBusinessAug 24, 2026 · 1 minMexico’s Economy Grew 1.4% in Q2, Inflation Stays in TargetRio Times
BusinessRio TimesBusinessAug 24, 2026 · 1 minLatin America’s Oil Money and the US Squeeze on IranRio Times
BusinessRio TimesBusinessAug 24, 2026 · 1 minChile’s Long-Term Borrowing Costs Hit an 18-Month High as Growth StallsRio Times
BusinessRio TimesBusinessAug 24, 2026 · 1 minArgentina’s Central Bank Reserves Reach a Record US$50.655 BillionRio Times
BusinessRio TimesBusinessAug 24, 2026 · 1 minMexico’s Economy Grew 1.4% in Q2, Inflation Stays in TargetRio Times